Accordingly, ATR or CHK1 inhibition decreases PD-L1 expression and may facilitate the T-cell-mediated killing of the tumor cell [35,36], which may be of particular interest in UCOGC characterized by frequent PD-L1 expression. Here, ATR is linked to neoplasm.